Dillard, P., Casey, N., Pollmann, S., Vernhoff, P., Gaudernack, G., Kvalheim, G., . . . Inderberg, E. M. (2021). Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors. Oncoimmunology.
Styl ChicagoDillard, Pierre, Nicholas Casey, Sylvie Pollmann, Patrik Vernhoff, Gustav Gaudernack, Gunnar Kvalheim, Sébastien Wälchli, a Else Marit Inderberg. "Targeting KRAS Mutations With HLA Class II-restricted TCRs for the Treatment of Solid Tumors." Oncoimmunology 2021.
Citace podle MLADillard, Pierre, et al. "Targeting KRAS Mutations With HLA Class II-restricted TCRs for the Treatment of Solid Tumors." Oncoimmunology 2021.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..